SCHEMBL7516533

SCHEMBL7516533

COc1ccc(Cc2ncnc3ccccc23)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.60
POLB P06746 1/20 0.60
NR2F2 P24468 1/20 0.60
SMN1; SMN2 Q16637 3/20 0.52
HTT P42858 2/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
LTA4H P09960 1/20 0.50
KDR P35968 6/20 0.49
ALDH1A1 P00352 3/20 0.49
LMNA P02545 2/20 0.49
PDE3B Q13370 1/20 0.48
PDE3A Q14432 1/20 0.48
PDE10A Q9Y233 1/20 0.48
MAPT P10636 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HSP90AB1 P08238 1/20 0.44
AKT1 P31749 1/20 0.44
AKT2 P31751 1/20 0.44
AKT3 Q9Y243 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1108399 0.82 EGFR (0.53) EGFRNR2F2SMN1; SMN2HTTNPC1
SCHEMBL7513679 0.81 APP (0.60) POLBSMN1; SMN2RAB9AALDH1A1LMNA
Hydrochloric Acid SCHEMBL7511516 0.80 APP (0.59) POLBSMN1; SMN2RAB9AALDH1A1LMNA
Hydrochloric Acid SCHEMBL7522378 0.80 APP (0.59) POLBSMN1; SMN2RAB9AALDH1A1LMNA
SCHEMBL7511027 0.80 EGFR (0.57) EGFRNR2F2SMN1; SMN2HTTNPC1
SCHEMBL28174587 0.77 LTA4H (0.56) HTTLTA4HKDRALDH1A1LMNA
SCHEMBL27887765 0.77 CCNC (0.43) EGFRPOLBNR2F2HTTNPC1
SCHEMBL7517528 0.76 AR (0.51) EGFRSMN1; SMN2HTTALDH1A1LMNA
SCHEMBL1445588 0.76 PDE10A (0.66) SMN1; SMN2HTTNPC1RAB9ALTA4H
SCHEMBL3112115 0.75 EGFR (1.00) EGFRPOLBNR2F2SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832073-B1 QUINAZOLINES AND PHARMACEUTICAL COMPOSITIONS SUGEN INC (US) 2002-01-16 EP claimed
EP-0832073-B1 QUINAZOLINES AND PHARMACEUTICAL COMPOSITIONS SUGEN INC (US) 2002-01-16 EP disclosed